- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Bendamustine USP Related Compound G
Bendamustine USP Related Compound G | CAS NO: 191939-34-1, also known as Bendamustine USP Related Compound G its chemical | IUPAC name is 4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid. Bendamustine USP Related Compound G is potential impurity of Bendamustine. Bendamustine works by interfering with the growth and spread of cancer cells. It's usually administered intravenously, and its side effects can include nausea, fatigue, and a risk of infection due to its effects on bone marrow. Synchemia Research chemical is manufacturer and Supplier of Bendamustine USP Related Compound G with comprehensive characterization data that adheres to regulatory guidelines, ensuring its suitability for pharmaceutical QC applications.
Synchemia Research chemical is a leading manufacturer, Supplier and exporter of high-quality Bendamustine USP Related Compound G | CAS NO: 191939-34-1, also known as Bendamustine USP Related Compound G. Multiple Myeloma: Typically used in combination with other medications.Off-label Uses: Sometimes used for other hematological malignancies or solid tumors, depending on the clinical scenario. Buy Reliable and High-Purity Bendamustine USP Related Compound G, Delivered by Synchemia Research Chemical.
| Product name | Bendamustine USP Related Compound G |
| SRC CAT No | SRC-B1422 |
| CAS No | 191939-34-1 |
| Mol.F. | C16H20ClN3O2S |
| Mol.Wt. | 353.9 g/mol |
| Related CAS No. | 2469039-29-8 (HCl salt) |
| Inv Status | Custom Synthesis |
